Unicycive Therapeutics, Inc.
No trades
No trades
Fundamentals and stats
Operating, investing, and financing activities
Free cash flow for Q2 26 is −7.60 M USD. For 2025, it was −31.34 M USD and operating cash flow was −31.32 M USD.
2018
2019
2020
2021
2022
2023
2024
2025
Cash flow from operating activities
Cash flow from investing activities
Cash flow from financing activities
MetricsCurrency: USD
2018
2019
2020
2021
2022
2023
2024
2025
TTM